同和药业：公司将于2026年4月底披露《2025年年度报告》

Core Viewpoint - Tonghua Pharmaceutical will disclose its 2025 annual report by the end of April 2026, indicating a commitment to transparency and future planning [2] Production Capacity - The second phase of the second plant is expected to achieve an annual production capacity of 1.5 to 1.6 billion yuan after the two workshops commence trial production [2] - Over the next 3-5 years, the total production capacity for raw materials is anticipated to exceed 2 billion yuan [2] - The utilization rate of the first plant is currently high, while the utilization rate of the second plant is gradually increasing [2] Orders and Demand - The company currently has a sufficient backlog of orders, suggesting strong demand for its products [2]